JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online April 15, 2008, 10.2967/jnumed.107.046987
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.046987v1
49/5/700    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Frost, M. L.
Right arrow Articles by Fogelman, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frost, M. L.
Right arrow Articles by Fogelman, I.
Journal of Nuclear Medicine Vol. 49 No. 5 700-707
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.046987

Clinical Investigation

Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism

Michelle L. Frost1, Glen M. Blake1, So-Jin Park-Holohan2, Gary J.R. Cook3, Kathleen M. Curran4, Paul K. Marsden5 and Ignac Fogelman1

1 King's College London, Osteoporosis Screening and Research Unit, Guy's Hospital, London, United Kingdom; 2 Molecular Medicine Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; 3 Department of Nuclear Medicine, Royal Marsden Hospital, London, United Kingdom; 4 School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland; and 5 King's College London, PET Imaging Centre, St. Thomas' Hospital, London, United Kingdom

Correspondence: For correspondence or reprints contact: Michelle Frost, Osteoporosis Screening and Research Unit, King's College London, Guy's Hospital Campus, St. Thomas St., London, SE1 9RT, U.K. E-mail: michelle.frost{at}kcl.ac.uk

18F-Fluoride PET allows noninvasive evaluation of regional bone metabolism and has the potential to become a useful tool for assessing patients with metabolic bone disease and evaluating novel drugs being developed for these diseases. The main PET parameter of interest, termed Ki, reflects regional bone metabolism. The aim of this study was to compare the long-term precision of 18F-fluoride PET with that of biochemical markers of bone turnover assessed over 6 mo. Methods: Sixteen postmenopausal women with osteoporosis or significant osteopenia and a mean age of 64 y underwent 18F-fluoride PET of the lumbar spine and measurements of biochemical markers of bone formation (bone-specific alkaline phosphatase and osteocalcin) and bone resorption (urinary deoxypyridinoline) at baseline and 6 mo later. Four different methods for analyzing the 18F-fluoride PET data were compared: a 4k 3-compartmental model using nonlinear regression analysis (Ki-4k), a 3k 3-compartmental model using nonlinear regression analysis (Ki-3k), Patlak analysis (Ki-PAT), and standardized uptake values. Results: With the exception of a small but significant decrease in Ki-3k at 6 mo, there were no significant differences between the baseline and 6-mo values for the PET parameters or biochemical markers. The long-term precision, expressed as the coefficient of variation (with 95% confidence interval in parentheses), was 12.2% (9%–19%), 13.8% (10%–22%), 14.4% (11%–22%), and 26.6% (19%–40%) for Ki-3k, Ki-PAT, mean standardized uptake value, and Ki-4k, respectively. For comparison, the precision of the biochemical markers was 10% (7%–15%), 18% (13%–27%), and 14% (10%–21%) for bone-specific alkaline phosphatase, osteocalcin, and urinary deoxypyridinoline, respectively. Intraclass correlation between the baseline and 6-mo values ranged from 0.44 for Ki-4k to 0.85 for Ki-3k. No significant correlation was found between the repeated mean standardized uptake value measurements. Conclusion: The precision and intraclass correlation observed for Ki-3k and Ki-PAT was equivalent to that observed for biochemical markers. This study provided initial data on the long-term precision of 18F-fluoride PET measured at the lumbar spine, which will aid in the accurate interpretation of changes in regional bone metabolism in response to treatment.

Key Words: 18F-fluoride PET • precision • bone metabolism • osteoporosis

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.